Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion type Assertion NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_head.
- NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion description "[The authors present here the clinical, anatomic, and endocrine-metabolic studies of three patients, with a view toward careful delineation of the syndrome and further characterization of the metabolic defect.The most striking and consistent metabolic derangements present in all of these patients were fasting hypoglycemia (less than 20 mg/dL), postprandial hyperglycemia (more than 250 mg/dL), marked hyperinsulinemia (more than 2000 ?U/mL), and severe insulin resistance (less than a 20 percent decrease in blood sugar with 0.3 to 1.0 U/kg of regular insulin IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_provenance.
- NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion evidence source_evidence_literature NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_provenance.
- NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion SIO_000772 7154104 NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_provenance.
- NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion wasDerivedFrom befree-20150227 NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_provenance.
- NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion wasGeneratedBy ECO_0000203 NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_provenance.